News

It’s time for organizations to expand the way they think about and employ PAs by looking at how the profession can impact areas where there are real needs.

Cindy Cooke, president of the American Association of Nurse Practitioners, shares 10 ways nurse practitioners reduce healthcare costs while improving quality.

FDA has approved sNDA for new formulation of fentanyl buccal soluble film (Onsolis, BioDelivery Sciences International) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.

While FDA is proposing that bevacizumab (Avastin) for macular degeneration be used within 5 days of re-packaging to avoid development of endophthalmitis in patients, that precaution may not be necessary, according to a new study.

Managing cardiovascular drug trend could prove challenging

Entresto is the first in a new class of drugs, valsartan combined with sacubitril, a pro-drug of a compound that is a receptor‐neprilysin inhibitor (ARNI). It is taken orally twice daily. It was approved for heart failure patients with reduced ejection fraction based on the PARADIGM-HF trial.

Methodist Healthcare Ministries of South Texas, Inc. is relying on data to identify the most effective ways to proactively engage patients, and leveraging technology to share information between facilities and programs.

Your input is needed! Managed Healthcare Executive is curious about your thoughts regarding the State of the Healthcare Industry. Take our survey and the feedback you provide will be invaluable in helping MHE. Complete the survey and you can be entered to win a $300 Visa gift card!

FDA recently granted special approval of pediatric use of OxyContin in patients aged 11 to 16 years, under specific conditions.

Here are five ways healthcare organizations of all types, including managed care organizations, can improve patient adherence to prescribed medication therapies.

A study of tocilizumab (Actemra) in the treatment of rheumatoid arthritis (RA) found that the number of serious adverse events (SAEs) found in postmarketing data were similar to other populations from clinical trials and epidemiology data.

A look at some of the technology tools healthcare systems are using to reduce readmissions.

Novo Nordisk is expected to find out in October whether FDA will approve its long-acting insulin Tresiba for sale in the US market. However, if approved, Tresiba faces growing competition from Sanofi, which markets the leading basal insulin Lantus along with Toujeo.

A Medicare reimbursement policy proposing that multiple biosimilars have the same pricing J-code for Medicare reimbursement purposes could ultimately result in fewer treatment options, according to a group representing the industry.

We asked the Managed Healthcare Executive editorial advisory board, what book would you recommend to other executives? Here's what they said.

Experts say the benefits of ICD-10 will far outweigh the risks. Here's why.

Although many states and the federal government are taking a close look at granting provider status for pharmacists, the two entities have slightly different priorities.

As healthcare systems move toward new payment and delivery models, physicians are the key to success.

G. William Hoagland, senior vice president of the Bipartisan Policy Center, believes that the Affordable Care Act and possible repeals toward it will be issues in the 2016 election.

Surprisingly, giving prescriptions to the wrong patients is still common in community pharmacies across the U.S. According to the Institute for Safe Medication Practices (ISMP), this error occurs about once in every 1,000 prescriptions dispensed.

FDA has approved azelaic acid (Finacea, Bayer HealthCare) Foam, 15% for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.

Pharmaceutical firms “underinvest” in long-term research to develop new cancer-fighting drugs because of the time and expense, according to a new study.

FDA approved epilepsy drug levetiracetam (Spritam), the first FDA-approved drug that utilizes three-dimensional printing (3DP).

Unichem Pharmaceuticals issued a voluntary recall of Hydrochlorothiazide Tablets 25 mg, 1,000-count bottle. The precautionary measure is due to the identification of a Clopidogrel tablet found in a bottle at one pharmacy.

Global sales of pharmaceuticals will soar to $1.3 trillion in 2018, led by new cancer and specialty drug introductions, a new report found.

FDA is warning that a case of definite progressive multifocal leukoencephalopathy (PML) and a case of probable PML have been reported in patients taking Gilenya (fingolimod) for multiple sclerosis (MS).

More Medicaid incentive programs are cropping up across the country. Here's a look at the programs, and some of the early results.

The Medicaid Incentives for Prevention of Chronic Diseases initiative, funded by the Department of Health and Human Services, is the biggest thing going in Medicaid wellness programs right now.

Drug and device makers are taking into account the health plans’ perspectives in the commercialization of their products, according to a new survey.